Eli Lilly 2007 Annual Report Download - page 131

Download and view the complete annual report

Please find page 131 of the 2007 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

© 2008 Eli Lilly and Company 2007AR
For More Information
Lilly corporate responsibility and report of political fi nancial support . . www.lilly.com/about/citizenship/index.html
Lilly clinical trials registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillytrials.com
Lilly Grant Offi ce . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillygrantoffi ce.com
Multi-drug resistant tuberculosis initiative . . . . . . . . . . . . . . . . . . . . . . . . . www.lillymdr-tb.com
Medicare prescription drug coverage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillymedicareanswers.com
Pharmaceutical industry patient assistance programs . . . . . . . . . . . . . . . www.pparx.org
Lilly Cares. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . www.lillycares.com or call toll-free 1-800-545-6962
Trademarks
Actos® (pioglitazone hydrochloride)
Alimta® (pemetrexed disodium)
Arxxant® (ruboxistaurin mesylate)
Axid® (nizatidine)
Byetta® (exenatide injection)
Ceclor® (cefaclor)
Cialis® (tadalafi l)
Coban® (monensin sodium), Elanco
Cymbalta® (duloxetine hydrochloride)
Effi ent™ (prasugrel)
Evista® (raloxifene hydrochloride)
Forteo® (teriparatide of recombinant DNA origin)
Gemzar® (gemcitabine hydrochloride)
Humalog® (insulin lispro of recombinant DNA origin)
Humatrope® (somatropin of recombinant DNA origin)
Humulin® (human insulin of recombinant DNA origin)
Permax® (pergolide mesylate)
Prozac® (fl uoxetine hydrochloride)
Prozac® Weekly™ (fl uoxetine hydrochloride)
ReoPro® (abciximab), Centocor
Rumensin® (monensin sodium), Elanco
Strattera® (atomoxetine hydrochloride)
Surmax® (avilamycin), Elanco
Symbyax® (olanzapine/fl uoxetine hydrochloride)
Tylan® (tylosin), Elanco
Vancocin® (vancomycin hydrochloride)
Xigris® (drotrecogin alfa [activated])
Yentreve® (duloxetine hydrochloride)
Zyprexa® (olanzapine)
Zyprexa® Zydis® (olanzapine)
Actos® is a trademark of Takeda Chemical Industries, Ltd.
AIR® is trademark of Alkermes, Inc.
Axid® is a trademark of Reliant Pharmaceuticals, LLC.
Byetta® is a trademark of Amylin Pharmaceuticals, Inc.
Cialis® is a trademark of Lilly ICOS LLC.
EVA® is a trademark of Stern Stewart & Co.
Sarafem® is a trademark of Galen (Chemicals) Limited
Vancocin® is a trademark of ViroPharma Incorporated
Zydis® is a trademark of Cardinal Health.
All trademarks listed above are trademarks of Eli Lilly and Company unless otherwise noted.